Wednesday, February 28th, 2007
Evotec and Interprotein Sign Collaboration Agreement to Develop Interleukin 6 Inhibitors to Treat Inflammatory Diseases (PR Newswire via Yahoo! Finance) (Illnesses diseases)
Evotec AG and Interprotein Corporation proudly announce today that they have signed a collaboration agreement on Interprotein’s Interleukin 6 inhibitors programme for the development of novel, orally active drugs treating inflammatory diseases.
Fundraiser aims to help Boyertown grad with debilitating diseases (The Mercury)
NEW HANOVER — For Lindsay Spengler, every single moment of her daily life is like living in an inferno.
Anti-oxidants of no benefit in prolonging life: Study (EARTHtimes.org)
Consuming Beta carotene, vitamins A and E and other antioxidant supplements to fight other diseases could in fact pose a serious health risk that could be fatal, according to a wide range of studies conducted by Center for Clinical Intervention Research at Denmark’s Copenhagen University Hospital.